SEARCH NEWS & VIEWS


Researchers Discover a Signal Driving Type 1 Diabetes
Scientists Develop New Method to 'Fingerprint' HIV
The Scripps Research Institute Expands New Board of Directors with the Appointment of Yucaipa Companies Founder and Philanthropist Ron Burkle

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US
1
Researchers Discover a Signal Driving Type 1 Diabetes

A potential therapy studied by the Oldstone Lab may stop type 1 diabetes from progressing past the prediabetic stage.

Scientists Develop New Method to 'Fingerprint' HIV

Findings from the Paulson Lab could guide vaccine design.

The Scripps Research Institute Expands New Board of Directors with the Appointment of Yucaipa Companies Founder and Philanthropist Ron Burkle

"Ron's business acumen and philanthropic mindset will be critical to realizing the new self-sustaining 'bench-to-bedside' model we are building," said Peter G. Schultz, Ph.D., President of TSRI and the California Institute for Biomedical Research (Calibr).

  • A Molecular On/Off Switch for CRISPR
  • Philip Dawson Named Dean of The Scripps Research Institute’s Graduate Program
  • These Two Molecules Appear to Drive Breast Cancer Drug Resistance
  • Mobile Technology Shakes Up Pregnancy Research
  • Potential Drug Candidates Halt Prostate and Breast Cancer Growth
  • Scripps Florida Scientists Develop New Drug Delivery Method for Cancer Therapy
  • In the Battle for Real Estate, a Disordered Protein Wins Out
  • New Enzyme-Like Tool Lets Chemists Modify Hard-to-Reach Spots on Drug Molecules
  • Scientists Take Aim at Obesity-Linked Protein
  • Researchers Find Standard Pacemakers and Defibrillators Safe for MRI Using a New Protocol
  • The Scripps Research Institute Announces New Board Members and Chairman of the Board
  • Watching the Clock: A Profile of Katja Lamia
  • Scientists Find Clue to Why Zika, But Not Its Close Relatives, Causes Birth Defects
  • Chemists Unveil Versatile New Method for Making Chiral Drug Molecules